SunTrust analyst William Chappell lowered his price target on Procter & Gamble to $75 after the company's in-line Q3 earnings and updated guidance. Chappell says the continued success of Laundry, Beauty, and Health Care segments are encouraging, but also sees "little visibility" on when he can expect Baby and Grooming segments' pricing environment to improve. The analyst keeps his Hold rating on Procter & Gamble amid ongoing issues in the Baby, Feminine & Family Care segment, with Q1 growth down 3% driven by 2% decline in volume and 1% decline in price.

Deutsche Bank lowered the firm's price target on Procter & Gamble to $171 from $172 and keeps a Buy rating on the shares following the fiscal Q3 report.

Raymond James raised the firm's price target on Procter & Gamble to $178 from $175 and keeps an Outperform rating on the shares after fiscal Q3 EPS of $1.52 came in well above the firm's estimate and consensus. P&G continues to grow profitability ahead of peers even as top-line growth decelerates, notes the firm, which raised its FY24 EPS estimate to $6.56 from $6.44.

Evercore ISI raised the firm's price target on Procter & Gamble to $177 from $175 and keeps an Outperform rating on the shares. While "understandably" the focus in the earnings call was on the drivers of sales slowing to 3%, comps considered, this 3% rate already marks a rebound versus prior Q2 on a two-year stack and three-year run rate basis, says the analyst, who adds that calendar 2025 Street expectations "strike us as conservative."